BioNTech SE (BNTX)
BioNTech SE Operating Income margin
| Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|
| Operating Income margin | 0.0% | (99.5%) | (42.2%) | (167.2%) | (17.1%) | 80.5% | 73.0% | 18.1% |
BioNTech SE (BNTX) Operating Income margin comparison analysis
BNTX key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is BioNTech SE's Operating Income margin?
As of today, Microsoft Corp's last 12-month Operating Income margin is (30.8%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Operating Income margin for BioNTech SE have been 48.5% over the past three years, and (6.9%) over the past five years.
2) Is BioNTech SE's Operating Income margin Good?
As of today, BioNTech SE's Operating Income margin is (30.8%), which is higher than industry median of (916.0%). It indicates that BioNTech SE's Operating Income margin is Good.